Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Financings
Financings
| Raise | Date |
|---|---|
| 0% convertible senior notes due 2031 Made bigger: US$300M · J. Wood Capital Advisors LLC Dealers: J. Wood Capital Advisors LLC Use of proceeds: Capped call transactions, repurchase of $25 million of common stock, repayment of the OrbiMed Purchase Agreement, general corporate purposes and MRD initiatives | Jun 17, 2026 |